![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Modi Marlene Martin Nancy Heathcote Jenny E Nieforth Keith Zeuzem Stefan
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.10, Iss.12, 2001-12, pp. : 2201-2213
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peginterferon- -2a (40kD): A Review of its Use in the Management of Chronic Hepatitis C
Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. :